ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Five Prime Therapeutics Inc.
38.00
0.0000
成交量:
- -
成交額:
- -
市值:
17.41億
市盈率:
-16.60
高:
38.00
開:
38.00
低:
38.00
收:
38.00
52周最高:
38.90
52周最低:
2.84
股本:
4,580.27萬
流通股本:
2,567.83萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-2.2894
每股收益(LYR):
-2.2894
淨資產收益率:
-40.58%
總資產收益率:
-17.19%
市淨率:
6.57
市盈率(LYR):
-16.60
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字:
Five Prime Therapeutics Inc.
交易所:
NASDAQ
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
http://www.fiveprime.com
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Five Prime Therapeutics, Inc.於2001年12月根據特拉華州法律註冊成立,是一家臨床階段的生物技術公司,致力於發現和開發新的蛋白質療法。蛋白質治療劑是阻斷疾病過程中細胞外蛋白質或蛋白質片段產生抗體或藥物,包括癌症和炎症性疾病。該公司沒有批准用於商業銷售的產品,到目前為止並沒從產品銷售中獲取任何收入。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/FPRX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FPRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FPRX\",,,,,undefined,":{"symbol":"FPRX","market":"US","secType":"STK","nameCN":"Five Prime Therapeutics Inc.","latestPrice":38,"timestamp":1618516800000,"preClose":38,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":25678289,"shares":45802740,"eps":-2.289406,"marketStatus":"停牌","change":0,"latestTime":"02-27 15:38:01 EST","open":38,"high":38,"low":38,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.289406,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1772226000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1379476800000,"exchange":"NASDAQ","adjPreClose":38,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FPRX\",,,,,undefined,":{"symbol":"FPRX","floatShares":25678289,"roa":"-17.19%","roe":"-40.58%","lyrEps":-2.289406,"shares":45802740,"dividePrice":0,"high":38,"amplitude":0,"preClose":38,"low":38,"week52Low":2.84,"pbRate":"6.57","week52High":38.9,"institutionHeld":0,"latestPrice":38,"eps":-2.289406,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.289406,"open":38,"prevYearClose":17.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FPRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-03-22","symbol":"FPRX","fiscalQuarterEnding":"2020/12","expectedEps":-0.5,"name":null,"time":"盤後","type":"earning","dateTimestamp":1616385600000,"reportTimeType":"post","actualEps":-0.51},{"date":"2020-11-03","symbol":"FPRX","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":"2020/09","expectedEps":-0.61,"defaultRemindTime":1604394000000,"name":null,"time":"","dateTimestamp":1604379600000,"actualEps":null},{"market":"US","date":"2020-08-06","symbol":"FPRX","fiscalQuarterEnding":"2020/06","expectedEps":-0.7,"name":null,"time":"盤後","type":"earning","dateTimestamp":1596686400000,"reportTimeType":"post","actualEps":-0.48},{"date":"2020-05-07","symbol":"FPRX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2020/03","expectedEps":-0.68,"defaultRemindTime":1588881600000,"name":null,"time":"盤後","dateTimestamp":1588824000000,"actualEps":null},{"date":"2020-02-27","symbol":"FPRX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/12","expectedEps":-0.97,"defaultRemindTime":1582837200000,"name":null,"time":"盤後","dateTimestamp":1582779600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FPRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FPRX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FPRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FPRX","date":"2021-04-20","current":-16.598192,"percent":0.167737,"low":-39.720739,"twenty":-17.980669,"median":-2.106798,"eighty":2.206531,"high":5.32454,"avg":-7.014537,"sd":10.93998,"marketCap":1740504120},"quantilePoints":[{"date":"2021-03-05","current":-18.019737,"twenty":-19.200834,"median":-2.115353,"eighty":2.204098,"marketCap":1708865700},{"date":"2021-03-12","current":-17.948606,"twenty":-18.685425,"median":-2.115353,"eighty":2.204098,"marketCap":1702120177},{"date":"2021-03-19","current":-17.859457,"twenty":-18.010253,"median":-2.106798,"eighty":2.206531,"marketCap":1693665931},{"date":"2021-03-26","current":-20.525633,"twenty":-18.004945,"median":-2.115353,"eighty":2.204098,"marketCap":1730885544},{"date":"2021-04-01","current":-20.460455,"twenty":-18.004945,"median":-2.115353,"eighty":2.204098,"marketCap":1725389215},{"date":"2021-04-09","current":-20.579948,"twenty":-17.980669,"median":-2.106798,"eighty":2.206531,"marketCap":1735465818},{"date":"2021-04-16","current":-20.639694,"twenty":-17.980669,"median":-2.106798,"eighty":2.206531,"marketCap":1740504120},{"date":"2021-04-20","current":-20.639694,"twenty":-17.980669,"median":-2.106798,"eighty":2.206531,"marketCap":1740504120}],"updateTime":1772224681595},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.fiveprime.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":-0.0089},{"period":"3month","weight":0.0086},{"period":"6month","weight":0.0686},{"period":"1year","weight":0.1594},{"period":"ytd","weight":0.0108}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Five Prime Therapeutics, Inc.於2001年12月根據特拉華州法律註冊成立,是一家臨床階段的生物技術公司,致力於發現和開發新的蛋白質療法。蛋白質治療劑是阻斷疾病過程中細胞外蛋白質或蛋白質片段產生抗體或藥物,包括癌症和炎症性疾病。該公司沒有批准用於商業銷售的產品,到目前為止並沒從產品銷售中獲取任何收入。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.029825},{"month":2,"riseRate":0.5,"avgChangeRate":0.008899},{"month":3,"riseRate":0.5,"avgChangeRate":0.073012},{"month":4,"riseRate":0.375,"avgChangeRate":-0.002547},{"month":5,"riseRate":0.428571,"avgChangeRate":0.057349},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.013532},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.051986},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.060151},{"month":9,"riseRate":0.571429,"avgChangeRate":0.003402},{"month":10,"riseRate":0.5,"avgChangeRate":0.126945},{"month":11,"riseRate":0.625,"avgChangeRate":0.443167},{"month":12,"riseRate":0.5,"avgChangeRate":0.069749}],"exchange":"NASDAQ","name":"Five Prime Therapeutics Inc.","nameEN":"Five Prime Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"FPRX\",market:\"US\",,,undefined,":null}}